High mortality among older patients treated with pentavalent antimonials for visceral leishmaniasis in East Africa and rationale for switch to liposomal amphotericin B
Published inAntimicrobial agents and chemotherapy, vol. 55, no. 1, p. 455-456
Publication date2011
Keywords
- Africa
- Age Factors
- Amphotericin B/therapeutic use
- Antiprotozoal Agents/therapeutic use
- Humans
- Leishmaniasis, Visceral/drug therapy/mortality
- Middle Aged
Citation (ISO format)
CHAPPUIS, François et al. High mortality among older patients treated with pentavalent antimonials for visceral leishmaniasis in East Africa and rationale for switch to liposomal amphotericin B. In: Antimicrobial agents and chemotherapy, 2011, vol. 55, n° 1, p. 455–456. doi: 10.1128/AAC.01298-10
Main files (1)
Article (Published version)
Identifiers
- PID : unige:25190
- DOI : 10.1128/AAC.01298-10
- PMID : 21078947
Journal ISSN0066-4804